Pfizer's New Chief Scientific Officer Charts R&D Vision For High And Low-Risk Investments

By Yahoo! Finance   |   1 year ago
Pfizer's New Chief Scientific Officer Charts R&D Vision For High And Low-Risk Investments

Pfizer is focusing on high-return opportunities in core capabilities like Oncology and anti-obesity medications, aligning with its strategic shift. The company aims to maintain a balanced project portfolio while emphasizing key areas and potential future market segments.

Read More

Did you find this insightful?